OBJECTIVES: Patients treated for major depressive disorder are at increased risk for sudden cardiac death. Impaired arterial baroreflex function has been associated with ventricular arrhythmias. Our hypothesis was that arterial baroreflex dysfunction prevails in major depressive disorder and that electroconvulsive therapy in conjunction to medical therapy would improve both depressive symptoms and baroreflex function. METHODS: Thirty-three patients with major depressive disorder who were treated in hospital were studied before and after electroconvulsive treatment. Eighteen patients underwent follow-up investigations 6 months after discharge. ECG and beat-to-beat blood pressures were recorded continuously. Arterial baroreflex sensitivity (BRS) and effectiveness index were calculated. Twenty healthy subjects were examined for comparison. RESULTS: Heart rate and systolic blood pressures were elevated (P < 0.01 for all) in depressive patients before treatment when compared with healthy subjects, whereas arterial BRS and baroreflex effectiveness were reduced (10 +/- 7 vs. 15 +/- 5 ms/mmHg and 0.35 +/- 0.20 vs. 0.48 +/- 0.14, P < 0.01 for both). Whereas depressive symptoms decreased after treatment (P < 0.05), blood pressures, heart rate, arterial BRS, and effectiveness remained unchanged. At follow-up, 6 months after discharge all variables were unchanged when compared with values obtained at discharge. CONCLUSION: Both the sensitivity and the number of times the arterial baroreflex is being active are reduced in major depressive disorder and this baroreflex dysfunction may prevail long-term when depressive symptoms have improved.
OBJECTIVES:Patients treated for major depressive disorder are at increased risk for sudden cardiac death. Impaired arterial baroreflex function has been associated with ventricular arrhythmias. Our hypothesis was that arterial baroreflex dysfunction prevails in major depressive disorder and that electroconvulsive therapy in conjunction to medical therapy would improve both depressive symptoms and baroreflex function. METHODS: Thirty-three patients with major depressive disorder who were treated in hospital were studied before and after electroconvulsive treatment. Eighteen patients underwent follow-up investigations 6 months after discharge. ECG and beat-to-beat blood pressures were recorded continuously. Arterial baroreflex sensitivity (BRS) and effectiveness index were calculated. Twenty healthy subjects were examined for comparison. RESULTS: Heart rate and systolic blood pressures were elevated (P < 0.01 for all) in depressivepatients before treatment when compared with healthy subjects, whereas arterial BRS and baroreflex effectiveness were reduced (10 +/- 7 vs. 15 +/- 5 ms/mmHg and 0.35 +/- 0.20 vs. 0.48 +/- 0.14, P < 0.01 for both). Whereas depressive symptoms decreased after treatment (P < 0.05), blood pressures, heart rate, arterial BRS, and effectiveness remained unchanged. At follow-up, 6 months after discharge all variables were unchanged when compared with values obtained at discharge. CONCLUSION: Both the sensitivity and the number of times the arterial baroreflex is being active are reduced in major depressive disorder and this baroreflex dysfunction may prevail long-term when depressive symptoms have improved.
Authors: A Frattola; G Parati; P Gamba; F Paleari; G Mauri; M Di Rienzo; P Castiglioni; G Mancia Journal: Diabetologia Date: 1997-12 Impact factor: 10.122
Authors: Tye Dawood; Elisabeth A Lambert; David A Barton; Dominique Laude; Jean-Luc Elghozi; Murray D Esler; Deepak Haikerwal; David M Kaye; Elodie J Hotchkin; Gavin W Lambert Journal: Hypertens Res Date: 2007-04 Impact factor: 3.872
Authors: Narendra N Khanna; Mahesh Maindarkar; Ajit Saxena; Puneet Ahluwalia; Sudip Paul; Saurabh K Srivastava; Elisa Cuadrado-Godia; Aditya Sharma; Tomaz Omerzu; Luca Saba; Sophie Mavrogeni; Monika Turk; John R Laird; George D Kitas; Mostafa Fatemi; Al Baha Barqawi; Martin Miner; Inder M Singh; Amer Johri; Mannudeep M Kalra; Vikas Agarwal; Kosmas I Paraskevas; Jagjit S Teji; Mostafa M Fouda; Gyan Pareek; Jasjit S Suri Journal: Diagnostics (Basel) Date: 2022-05-17
Authors: Ida T Fonkoue; Paul J Marvar; Seth Norrholm; Yunxiao Li; Melanie L Kankam; Toure N Jones; Monica Vemulapalli; Barbara Rothbaum; J Douglas Bremner; Ngoc-Anh Le; Jeanie Park Journal: Brain Behav Immun Date: 2019-11-01 Impact factor: 7.217
Authors: Alexandra Pinter; Szabolcs Szatmari; Tamas Horvath; Ana Isabel Penzlin; Kristian Barlinn; Martin Siepmann; Timo Siepmann Journal: Neuropsychiatr Dis Treat Date: 2019-05-17 Impact factor: 2.570